Erin Brodwin is a Health Tech Reporter at Axios. She covers a range of topics within the healthcare sector, including digital health, consumer health, and the intersection of artificial intelligence and medicine, with a focus on telehealth and wellness programs. Erin's work has been featured in notable outlets such as STAT News, Yahoo News, Business Insider, and RamaOnHealthcare.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Erin Brodwin's coverage heavily focuses on the intersection of technology and healthcare, with emphasis on exclusive reports, citing data, and private sector announcements. She would likely be receptive to pitches that provide unique insights into health tech companies' valuations, M&A activities in the digital health space, or trends in women's health startups.
Given her focus on exclusive reports and data citation, Erin may be interested in receiving pitches from industry experts who can offer insider perspectives or access to proprietary data related to emerging trends in healthcare technologies.
As she doesn't have a specific geographic focus mentioned, it appears that she takes an international view of these topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Revenue cycle management technology is having a moment as providers face margin pressure and staffing shortages.
Floreo is awaiting FDA review of its device and is planning a Series B round in the meantime.
Backers still see promise.
New research finds
This week we brought you
DW Healthcare Partners hired
This week
Investors are watching for a steadier regulator.
Following Axios' Future of Health Summit
Lilly is placing a $1.9 billion bet that rewriting RNA may succeed where gene therapy and gene editing have struggled.
